WST vs ATR vs GTLS vs SEE vs ESAB

For growth investors, West Pharmaceutical Services, Inc.

(WST) is the stronger pick with 6. 3% revenue growth year-over-year, versus -0. 6% for Sealed Air Corporation (SEE). Sealed Air Corporation (SEE) offers the better valuation at 12. 3x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate West Pharmaceutical Services, Inc. (WST) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Sealed Air Corporation (SEE) is the cheapest at 12.

3x versus Chart Industries, Inc. at 628. 5x. On forward P/E, Sealed Air Corporation is actually cheaper at 12. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AptarGroup, Inc. wins at 1. 75x versus Sealed Air Corporation's 9. 73x — a reasonable growth-adjusted valuation.

Over the past 5 years, ESAB Corporation (ESAB) delivered a total return of +107.

2%, compared to -19. 1% for Sealed Air Corporation (SEE). Over 10 years, the gap is even starker: GTLS returned +772. 5% versus SEE's +4. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Sealed Air Corporation (SEE) is the lower-risk stock at 0.

32β versus ESAB Corporation's 1. 24β — meaning ESAB is approximately 283% more volatile than SEE relative to the S&P 500. On balance sheet safety, West Pharmaceutical Services, Inc. (WST) carries a lower debt/equity ratio of 13% versus 3% for Sealed Air Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), West Pharmaceutical Services, Inc.

(WST) is pulling ahead at 6. 3% versus -0. 6% for Sealed Air Corporation (SEE). On earnings-per-share growth, the picture is similar: Sealed Air Corporation grew EPS 89. 5% year-over-year, compared to -92. 0% for Chart Industries, Inc.. Over a 3-year CAGR, GTLS leads at 38. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

West Pharmaceutical Services, Inc.

(WST) is the more profitable company, earning 16. 1% net margin versus 1. 0% for Chart Industries, Inc. — meaning it keeps 16. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WST leads at 20. 1% versus 13. 5% for SEE. At the gross margin level — before operating expenses — WST leads at 35. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, AptarGroup, Inc. (ATR) is the more undervalued stock at a PEG of 1. 75x versus Sealed Air Corporation's 9. 73x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Sealed Air Corporation (SEE) trades at 12. 4x forward P/E versus 37. 3x for West Pharmaceutical Services, Inc. — 25. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ESAB: 43. 2% to $146. 67.

All stocks in this comparison pay dividends.

Sealed Air Corporation (SEE) offers the highest yield at 1. 9%, versus 0. 3% for West Pharmaceutical Services, Inc. (WST).

For long-horizon retirement investors, Sealed Air Corporation (SEE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

32), 1. 9% yield). Both have compounded well over 10 years (SEE: +4. 4%, ESAB: +107. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (WST (Healthcare) and ATR (Healthcare) and GTLS (Industrials) and SEE (Consumer Cyclical) and ESAB (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: WST is a mid-cap quality compounder stock; ATR is a small-cap quality compounder stock; GTLS is a small-cap quality compounder stock; SEE is a small-cap deep-value stock; ESAB is a small-cap quality compounder stock. ATR, SEE pay a dividend while WST, GTLS, ESAB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.